A Study of SB751689 in Japanese Postmenopausal Women
NCT00554255
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoporosis
Interventions
DRUG:
SB751689
Sponsor
GlaxoSmithKline